Medicaid beneficiaries who may be affected will receive advance notice before any changes take effect. Under the $81 billion state budget, which reduced funding for the Michigan Department of Health and Human Service by 20%, pharmaceutical appropriations for GLP-1 drugs were reduced by $240 million, according to the nonpartisan House Fiscal Agency
brightens n smoothes skin for a more radiant and youthful complexion
In 2025, the GLP-1 therapeutic category solidified its position as one of the most dynamic segments in the global health industry, driven by policy validation, strategic competition among major pharmaceutical players, and expanding indications beyond glycemic control, reports MBN
Documentation: QR on label links to batch data and chromatogram for traceability
Eli Lilly has struck a deal that could reach $870 million in total value, striking a collaboration and licensing pact with Camurus to create long-acting versions of molecules against GLP-1 and other incretins
In regards to the questions about enforcement of SB855, we have prosecuted several matters involving health plan non compliance with SB855